Glaucoma challenges the survival of retinal ganglion cell axons in the optic nerve through processes dependent on both aging and ocular pressure. Relevant stressors likely include complex interplay between axons and astrocytes, both in the retina and optic nerve. In the DBA/2J mouse model of pigmentary glaucoma, early progression involves axonopathy characterized by loss of functional transport prior to outright degeneration. Here we describe novel features of early pathogenesis in the DBA/2J nerve. With age the cross-sectional area of the nerve increases; this is associated generally with diminished axon packing density and survival and increased glial coverage of the nerve. However, for nerves with the highest axon density, as the nerve expands mean cross-sectional axon area enlarges as well. This early expansion was marked by disorganized axoplasm and accumulation of hyperphosphorylated neurofilamants indicative of axonopathy. Axon expansion occurs without loss up to a critical threshold for size (about 0.45e0.50 mm 2 ), above which additional expansion tightly correlates with frank loss of axons. As well, early axon expansion prior to degeneration is concurrent with decreased astrocyte ramification with redistribution of processes towards the nerve edge. As axons expand beyond the critical threshold for loss, glial area resumes an even distribution from the center to edge of the nerve. We also found that early axon expansion is accompanied by reduced numbers of mitochondria per unit area in the nerve. Finally, our data indicate that both IOP and nerve expansion are associated with axon enlargement and reduced axon density for aged nerves. Collectively, our data support the hypothesis that diminished bioenergetic resources in conjunction with early nerve and glial remodeling could be a primary inducer of progression of axon pathology in glaucoma.
Introduction
Loss of vision in glaucoma is associated with the degeneration of retinal ganglion cell neurons (RGCs) and their axons, which comprise the optic nerve (Quigley, 1999; Whitmore et al., 2005; Nickells, 2007) . While age is the greatest risk factor for glaucoma, sensitivity to intraocular pressure (IOP) is the only modifiable risk factor (Tuck and Crick, 1998; Gordon et al., 2002) . Nevertheless, neurodegeneration in glaucoma often persists despite clinical management of IOP (Leske et al., 2003) . Thus, it is important in deciphering the early events involved in RGC degeneration to discriminate factors associated with IOP from those associated with aging.
Age and IOP combine in different ways to influence the onset and progression of RGC axon degeneration in the optic nerve (Crish et al., 2010; Calkins, 2013) . In the nerve head, where RGC axons pass unmyelinated from the retina to the nerve proper, aging stiffens important connective tissues and extracellular matrix, compromises the blood supply, and influences the biochemistry of astrocyte glia that help support axons (reviewed in Hernandez, 2000; Burgoyne, 2011) . These factors, collectively termed "remodeling", are likely to contribute to normal age-related loss of RGC axons and may increase susceptibility in glaucoma to IOP-related stress (Calkins, 2013) .
In terms of key pathogenic events in glaucoma, age is the critical determinant for degradation of anterograde RGC axonal transport from the retina to central brain targets, with IOP serving as an additional stressor (Crish et al., 2010 (Crish et al., , 2013 . We have shown in an inducible model and in the DBA/2J mouse model of hereditary glaucoma that deficits in transport mark a period of functional axonopathy prior to frank degeneration of RGC axons. The DBA2J presents age-dependent elevations in IOP that are normally absent in other mouse strains (Danias et al., 2003; Schuettauf et al., 2004; Zhou et al., 2005; Jakobs et al., 2005; Inman et al., 2006; . These elevations arise from closure of the drainage canals in the anterior segment induced by iris atrophy and pigment dispersion caused by mutations in the tyrp1 and gpnmb genes, respectively (John et al., 1998; Chang et al., 1999; Anderson et al., 2002; Howell et al., 2007a) . This ocular phenotype presents prominently in a large fraction of animals by 5e8 months of age with phenotypical penetrance of about 50% by 10e11 months (Sheldon et al., 1995; John et al., 1998; Libby et al., 2005; Scholz et al., 2008) . However, a small fraction of animals may demonstrate iris defects and elevated IOP as early as 2e4 months (Inman et al., 2006; Saleh et al., 2007) . Conversely, even for older ages, a fraction of animals may retain normal IOPs and RGC and axonal numbers (Schlamp et al., 2006; Inman et al., 2006) . Because of this variability across ages, the DBA/2J is a useful model system for probing the differences between age-and IOP-related axonal pathology in the optic nerve.
In the central nervous system, space once occupied by axons that are lost through disease or injury is generally filled by a glial scar, predominantly involving hypertrophic astrocyte processes. So too does reactive astrocyte gliosis contribute to remodeling in the optic nerve, including the DBA2J mouse (Jakobs et al., 2005; Bosco et al., 2008; Sun and Jakobs, 2012) . Here we ask whether optic nerve remodeling in the DBA2J includes other, perhaps earlier components that might presage overt axon degeneration. We find that with age, the DBA2J optic nerve enlarges, typically coincident with axon loss and increased gliosis. However, before axons are lost, they too expand with loss of cytoskeletal integrity. This predegenerative expansion in axon size is accompanied by retraction of astrocyte processes from the inter-axonal space and reduction in local mitochondria.
Materials and methods

Animals
All animal work and experimental procedures were approved by The Vanderbilt University Medical Center Institutional Animal Care and Use Committee. DBA/2J and C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, ME). Some DBA/2J mice were bred in a pathogen-free facility and regularly backcrossed with fresh founders from Jackson Laboratories to minimize uncontrolled genetic drift, as described (Inman et al., 2006; Buckingham et al., 2008) . In all cases, mice were maintained in a 12 h lightedark cycle with standard rodent chow available ad libitum.
A total of 91 DBA/2J mice were used in this study. We measured IOP in a subset of these representing 40 eyes using the Tono-Pen XL from Medtronic Solan (Jacksonville, FL) as described previously (Inman et al., 2006; Crish et al., 2010) . Briefly, prior to measurement, the mice were anesthetized (Avertin, 1.3% tribromoethanol, 0.8% tert-amyl alcohol) and proparacaine ophthalmic solution (0.5% proparacaine hydrochloride, Bausch&Lomb, Tampa, FL) was applied topically to the eye. Monthly IOP for each eye was taken as the average of 25e30 Tono-Pen measurements recorded during a session. Previously we demonstrated that IOP measured this way increases nearly monotonically after about 4 months of age until about 10 months so that mean lifetime IOP was an accurate reflection of inter-animal differences across ages (Inman et al., 2006) .
Tissue preparation and histopathology
Mice were perfused with 4% paraformaldehyde (PFA) in 0.1 M phosphate buffer (PB), pH 7.4, and the eyes with the optic nerve attached were carefully dissected from the orbit. A 1e2 mm section of optic nerve proximal (0.3e0.6 mm) to the globe was isolated, post-fixed for 1 h in 4% PFA and embedded in Epon resin and semithin (light microscopy) and ultra-thin (electron microscopy) crosssectioned as previously described (Sappington et al., 2003; Inman et al., 2006; Buckingham et al., 2008) . Nerve images were Fig. 1 . Nerve size increases with age in DBA/2J mice. A. Cross-sections through 3 month (left) and 13 month (right) DBA/2J optic nerve about 0.2 mm proximal to the globe demonstrate different cross-sectional areas (0.083 vs. 0.11 mm 2 , respectively). Enlargement of the older nerve was accompanied by increased glial coverage and diminished axon packing. B. Cross-sectional area of individual DBA/2J optic nerves compared to C57 nerves across ages. DBA/2J nerve area increases with age (r ¼ 0.54, p < 0.001), while C57 does not (r ¼ 0.03, p ¼ 0.84). C. IOP (mmHG) increases with age across our sample (r ¼ 0.57, p < 0.001) D. Nerve size tends to increase also with IOP in the DBA/2J, but this is not significant (r ¼ 0.19, p ¼ 0.17). Scale ¼ 100 mm (A). obtained using an Olympus Provis AX70 microscope equipped with a motorized X-Y-Z stage, a digital video camera, and 100Â oilimmersion, differential interference contrast optics. We collected photomicrographs from 1 to 2 mm thick cross-sections of nerve en montage so that the entire surface area was represented. Each micrograph was contrast and edge-enhanced using macro-routines written using the ImagePro software package (Media Cybernetics, CA). For ultrastructural analysis, 70 nm cross-sections were photographed at high magnification (5000e15,000Â) using a Philips CM-12, 120 keV transmission electron microscope Vanderbilt University Research Electron Microscopy Resource.
For immunochemistry of optic nerve, 6 mm paraffin sections were taken and stained for phosphorylated neurofilaments (SMI31, 1:1000, Covance, Nashville, TN) and glial fibrillary acidic protein (GFAP, 1:500, DAKO, Carpinteria, CA). SMI31 is a mouse monoclonal antibody that reacts with extensively phosphorylated heavy-chain neurofilament with small cross-reactivity with medium-chain neurofilament (Manufacturer's specification sheet; Sternberger et al., 1982; Sternberger and Sternberger, 1983) . It has been shown to react specifically in most mammals and some other vertebrates. Pre-treating the tissue with phosphatase abolished all staining (Sternberger and Sternberger, 1983) . The GFAP antibody (Code: Z 0334) was raised in rabbit against GFAP isolated from cow spinal cord. It reacts in most mammals and has shown to be specific to GFAP through crossed immunoelectrophoresis and indirect ELISA (Manufacturer's specification sheet) and omitting this antibody abolishes staining (Castellano et al., 1991) .
Axon quantification
For measuring cross-sectional nerve area, we used a total of 110 DBA/2J optic nerves and 45 C57 nerves. For a subset of 46 DBA/2J nerves, we measured axon density (axons/mm 2 ) as described previously (Inman et al., 2006; Buckingham et al., 2008) . Briefly, from each nerve montage obtained as described above, we randomly choose 25e30 non-overlapping frames encompassing a known area of optic nerve. Additional routines were used to identify and count each axon for which a single, intact myelin sheath could be identified. Nerves with pathology so severe that identification of intact myelin sheaths was ambiguous were excluded from this study. The mean of the axon density measurements within sampling frames was taken as the representative density of the nerve. For these same 46 nerves, we also measured the internal crosssectional area of each identified axon, exclusive of the myelin sheath. For each nerve, a range of 6000e40,000 axon measurements were used to calculate mean axon area (reported in mm 2 ). For a subset of 29 of these 46 nerves, degenerating axon profiles were counted manually in a representative cross-section; these were identified by densely packed multi-laminar myelin sheaths. For 10 of the 46 nerves, we counted mitochondria in 10 electron micrographs each of area~40 mm 2 . For these nerves, the number of mitochondria per unit area was expressed as the mean ± standard error. For all data, correlation coefficients were calculated from best-fitting regression lines using Pearson's coefficient (r).
Glial area analysis
To measure the fraction of each nerve area covered by glia, the montages from 43 nerves were filtered using a suite of MATLAB routines (MathWorks, Natick, MA) that highlighted glial processes separate from axons. These routines detected glial boundaries in contrast-enhanced binary images of each nerve by edge enhancement and size filtering to exclude axons. Noise from small axons was eliminated from this image based on a roundness and demonstrates tight packing of axons (5.8 Â 10 5 axons/mm 2 ) interspersed with thin astrocyte processes. B. A larger three month DBA/2J nerve (0.095 mm 2 ) with diminished axon packing (2.0 Â 10 5 axons/mm 2 ) and increased astrocyte hypertrophy (arrowheads). Axons also appear larger. C. A 10 month nerve (0.093 mm 2 ) with extensive gliosis and numerous degenerating axon profiles with multi-laminar myelin sheaths (*). D. Electron micrograph through same nerve in C highlights multi-laminar degenerating profiles (*). Scale ¼ 5 mm (A, B, C) or 2 mm (D). size filter. We calculated the percentage of the nerve occupied by glial processes by summing the area of all identified processes. Finally, the outer boundary of the nerve was outlined from the original montage and eroded to exclude pia and dura mater. Each binary image was segmented into 20 concentric divisions that each represented an interval of 5% of the total nerve area from the outer boundary of the nerve (division 1) to the center (division 20). This was achieved using a structuring element that reduced the area within the outline of the nerve by 5% with each subsequent iteration. This accounted for any irregularities in the shape of the outer boundary of the nerve to produce a consistent area for each division. The percent glial area for each division was calculated to produce a distribution from edge to center. The center of mass of this distribution was computed as the location along the radius of the nerve which delineates 50% of the total glial area on either side.
Results
Optic nerve enlargement with age involves axon pathology
In related studies of the DBA/2J optic projection (e.g., Inman et al., 2006; Bosco et al., 2008; Crish et al., 2010) , we noticed an interesting trend. Older DBA2J optic nerves tended to have a larger cross-sectional area. For example, the comparison in Fig. 1A shows a 3 month nerve next to a 13 mo nerve with about 20% greater area. Though variability was quite high at a given age, cross-sectional area increased at a rate of about 0.01 mm 2 every three months ( Fig. 1B) , growing from about 0.07 mm 2 at 1.5 months to about 0.12 mm 2 at 13 months. In contrast, C57 nerves did not increase with age, though the range of sizes too was highly variable (data not shown). As expected IOP increased with age in our DBA/2J sample (r ¼ 0.57, p < 0.001; Fig. 1C ), so it is not surprising that nerve size also tended to increase with IOP ( Fig. 1D ). Even so, IOP was not as strong a predictor of nerve size as age was (Fig. 1B) . This was so not only for the overall group (p ¼ 0.17), but also for restricted age subsets. For example, at 6e8 months IOP ranged from 16 to 21 mmHG, but did not correlate with nerve size (r ¼ 0.05, p ¼ 0.81; data not shown). For older animals (9e13 months), IOP ranged to over 25 mmHG but also did not strongly influence nerve size (r ¼ 0.27, p ¼ 0.28; data not shown). Thus, age was the primary determinant of nerve expansion.
Optic nerves that were larger also demonstrated overt pathology associated with RGC axon loss, as in Fig. 1A . A young DBA/2J nerve unaffected by disease can demonstrate a mean axon packing density as high as 5.0e6.0 Â 10 5 axons/mm 2 (Inman et al., 2006) . This density, when multiplied by nerve area, corresponds to a total number of axons of 40,000e60,000, comparable to that in a young C57/B6 nerve (Williams et al., 1996; Scholz et al., 2008) . In such nerves, axons are bundled in well-defined fascicles separated by thin astrocyte glial processes ( Fig. 2A ). We found that with expansion, nerves become disorganized, with smaller and more irregular fascicles framed by hypertrophic astrocyte processes and containing notably larger axons (Fig. 2B ). Many larger nerves also showed increased numbers of degenerating axon profiles identified by their multi-laminar myelin sheaths (Fig. 2C,D) .
When quantified, the morphological features described in Fig. 2 support the idea that enlargement of the optic nerve is indicative of axon pathology. Increased nerve size was associated with significantly diminished axon density and increased numbers of degenerating axon profiles (Fig. 3A,B) . Similarly, the mean crosssectional area of axons also increased with nerve size (Fig. 3C ), a feature we describe in more detail below. While there was a tendency for glial coverage of the nerve to increase, this was not significant ( Fig. 3D) . A better predictor of glial area in the nerve was axon density: as density decreased, glial coverage increased significantly (r ¼ 0.71, p < 0.001; data not shown).
Optic nerve and axon expansion precede axon loss
Next we present evidence that nerve and axon expansion occur prior to overt axon loss in the DBA/2J. The electron micrographs in Fig. 4A,B show a 4 month nerve side-by-side with a 9 month nerve that was 32% larger. The 9 month nerve also had a 39% larger mean axon area, 0.40 vs. 0.31 mm 2 , which is quite evident in the micrographs. Even so, axon density in the 9 month nerve was among the highest in our sample, 6.2 Â 10 5 axons/mm 2 , comparable to density Fig. 4 . Axons enlarge prior to degeneration. A. Low magnification electron micrograph of 4 month nerve with tight axonal packing (5.6 Â 10 5 axons/mm 2 ), nerve area of 0.069 mm 2 , and mean axon area of 0.31 mm 2 . Arrowheads indicate ramifying astrocyte processes. B. Larger 9 month nerve (0.091 mm 2 ) has larger mean axon area (0.40 mm 2 ) but comparable density (6.0 Â 10 5 axons/mm 2 ). C. Higher magnification electron micrograph of a small 9 month nerve (0.08 mm 2 ) and mean axon area of 0.35 mm 2 . Axon density was 6.2 Â 10 5 axons/mm 2 . Mitochondria in axons and astrocyte processes (arrowheads) are indicated (m). D. Larger 9 month nerve (0.095 mm 2 ) has expanded mean axon area of 0.41 mm 2 but comparable axon density (6.0 Â 10 5 axons/mm 2 ). E. High power image of nerve in C demonstrates well-ordered packing of neurofilaments and microtubules in axoplasm (dashed square) and prominent axolemma separating the axoplasm and myelin sheath (arrows). F. Enlarged axon from nerve in D shows disordered axoplasm, phagocytic vacuole (*) and little or no distinguishable axolemma. Scale ¼ 5 mm (A, B) , 0.5 mm (C, D) and 0.25 mm (E, F).
in the 4 month nerve (5.6 Â 10 5 axons/mm 2 ). Similarly, for two 9 month nerves (Fig. 4C,D) , axon density was quite high for each, 6.2 vs. 6.0 Â 10 5 axons/mm 2 , though the nerve in Fig. 4D was larger (0.095 mm 2 vs. 0.08 mm 2 ) with expanded axons (0.40 mm 2 vs. 0.35 mm 2 ). At higher magnifications, the axoplasm in the larger nerve appeared highly disordered with poorly articulated microtubules and neurofilaments, compared to axons in the smaller nerve (Fig. 4E,F) . Also, the axolemma that normally separates the axoplasm from the myelin sheath, quite evident in the smaller 9 month nerve (Fig. 4E) , was nearly indistinguishable in the larger nerve (Fig. 4E ). This change suggests that increased axon area prior to loss involves distended axoplasmic volume.
The comparisons of equal-density nerves in Fig. 4 suggest that axonal and nerve enlargement are pre-degenerative, in that expansion can occur without frank loss of axons. To determine the critical threshold at which axon enlargement is associated with axon loss, we ranked the nerves in our sample from highest to lowest axon density. We then compared density with mean cross-sectional axon area for increasingly inclusive density ranges (Fig. 5 ). For the top 20th percentile in density (5.6e6.2 Â 10 5 axons/mm 2 ), the span of mean axon areas was modest (0.28e0.40 mm 2 ) and the slope of the best-fitting regression line did not differ from zero (p ¼ 0.45). This indicates density did not change with axon size over this range. For the top 40% nerves, the range of axon areas increased to 0.45 mm 2 , but the slope of the regression line still did not differ from zero (p ¼ 0.74). For the 60 th percentile group, the range of axon areas increased to nearly 0.50 mm 2 , and axon density approached a negative correlation with axon area (r ¼ À0.28, p ¼ 0.14). By the 70 th percentile, axon density and area were negatively correlated (r ¼ À0.36, p ¼ 0.03). For the entire sample, axon area ranged to almost 0.75 mm 2 , and the decrease in axon density with increasing axon size was highly significant (r ¼ À0.60, p < 0.001). Thus, axon density can remain high and relatively invariant with increasing axon area up to a certain threshold of approximately 0.50 mm 2 . This is just about twice the size of the smallest mean axon area in our sample. Fig. 5 also shows that as the density range became more inclusive of lower values and the range of axon sizes increased, the average nerve size also increased. This is consistent with the overall negative correlation between axon density and nerve size for the entire sample (Fig. 3A) .
Retraction of astrocyte processes with early axon expansion
The micrographs in Fig. 4 hint at another feature of axon expansion prior to outright loss. We noticed that for high axon density nerves, increased nerve and axon size was accompanied by apparent reduction in astrocyte processes within the extra-axonal and inter-fascicular space (e.g., Fig. 4A,B ). This trend is illustrated more clearly below for two young DBA/2J nerves with comparable axon density: 5.2 Â 10 5 axons/mm 2 (Fig. 6A ) and 5.1 Â 10 5 axons/ mm 2 (Fig. 6B ). Compared to the smaller nerve (0.075 mm 2 ; Fig. 6A ), mean axon size in the larger nerve (0.10 mm 2 ; Fig. 6B ) was increased: 0.46 mm 2 vs. 0.37 mm 2 . This expansion in axon size was accompanied by diminished ramification of astrocyte processes with less separation between axon bundles. This change was evident also in the next comparison. Fig. 6C shows an electron micrograph of a small 9 month nerve (0.076 mm 2 ) with axon density of 5.7 Â 10 5 axons/mm 2 and mean axonal area of 0.28 mm 2 .
An adjacent section through the same nerve demonstrated modest levels of phosphorylated neurofilament in axons highlighted by typical ramification of GFAP-labeled astrocyte processes (Fig. 6D ). Another 9 month nerve that was larger (0.11 mm 2 ) had the same axon density but significantly expanded axons (0.41 mm 2 ) with increased levels of phosphorylated neurofilament and greatly reduced ramification of GFAP-labeled astrocytes (Fig. 6E,F) . Thus, it appears that axon expansion prior to frank loss of axon density is accompanied by a reduction in glial ramification.
To investigate this phenomenon further, we devised a simple algorithm to characterize the degree and pattern of glial ramification in a subset of nerves. This algorithm applies a series of sequential filters to separate ramifying glial processes from axons in an outline of each nerve. We then superimposed on the resulting binary image 20 concentric divisions, each representing 5% of the total nerve area. Fig. 7 shows two examples: an 11 month nerve with glial processes that distribute about evenly across divisions (Fig. 7A ) and a 6 month nerve with a higher concentration of ramification near the edge (Fig. 7B) . Accordingly, for the first nerve, each division has about 20% of its area covered by glia ( Fig. 7C) , while for the other nerve, divisions near the edge have increasingly greater glial coverage, rising to over 60% for the first few divisions (Fig. 7D) . This difference is reflected in the center of mass (CoM) for each distribution, which divides the distribution of glial area per division into halves. While the CoM for the nerve in Fig. 7A lies near Fig. 5 . Axon expansion eventually leads to loss. Axon density vs. mean axon area for nerves ranging from the highest density group (top 20 % ) to the entire sample. Bestfitting linear regression is included for each group. Density and axon area become negatively correlated by the 70 th percentile (r ¼ À0.36, p ¼ 0.03). For each ranking, the average cross-sectional nerve area for the group is given. the 10th division, indicating equivalent glial area between the center and edge of the nerve, the CoM for the other nerve is closer to 8, indicating a shift towards the edge (Fig. 7D ).
Next we calculated the CoM of the glial distribution for nerves with mean axon areas below 0.50 mm 2 (Fig. 8, left panel) . We chose this value because it represents the approximate threshold above which axon density diminishes (see Fig. 5 ). For nerves with the smallest mean axon size, the CoM is near 10 e indicating an even distribution of glial coverage from center to edge. As axon size increases in this subset of nerves, CoM diminishes. This is consistent with movement of glial processes out of the center and towards the edge of the nerve, as shown for the nerve in Fig. 7B . We repeated this analysis for a larger population of DBA/2J nerves, including those with much larger mean axon size (Fig. 8, right panel) . With increasing axon size, the CoM returns to higher values, though never exceeding 10 or 11. This indicates that as axons continue to expand glial ramification once again covers the nerve about evenly.
Early axon expansion involves diminished mitochondrial density
Our micrographs show another feature of associated with early axon expansion. We found that for nerves with axon density among the highest in our sample, as mean cross-sectional axon area increased along with nerve size, the number of discernible mitochondria in our electron micrographs seemed to diminish. For example, a small 4 month nerve with small axon size had mitochondria distributed throughout both axons and glial processes Fig. 6 . Increased Axon Size is accompanied by astrocyte withdrawal. A. Light micrograph of cross-section through young (1.5 mo) DBA/2J optic nerve demonstrates tight packing of axons (5.2 Â 10 5 axons/mm 2 ) separated by glial processes (arrowheads). Nerve area is 0.075 mm 2 and mean axon area is 0.37 mm 2 . B. A 5 month nerve has similar axon density (5.1 Â 10 5 axons/mm 2 ) but is larger (0.10 mm 2 ) with increased axon area (0.46 mm 2 ) and diminished astrocyte ramification (arrowheads). C. Electron micrograph of a small 9 month nerve (0.076 mm 2 ) with axon density of 5.7 Â 10 5 axons/mm 2 interspersed with glial processes (arrowheads). Mean cross-sectional area of axons was 0.28 mm 2 . D. Cross-section through same nerve as C with astrocyte processes labeled with antibodies against GFAP (red) and axons labeled for phosphorylated neurofilaments (pNF, green). E. A 9 month nerve with same axon density was larger (0.11 mm 2 ) and had significantly expanded axon area (0.41 mm 2 ) with less inter-axonal space. F. Immuno-labeling of same nerve demonstrates increased phosphorylated neurofilaments in axons and greatly reduced ramification of GFAP-labeled astrocytes. Scale ¼ 5 mm (A, B) , 1 mm (C, E) and 10 mm (D, F).
within the inter-axonal space (Fig. 9A) . In contrast, an older, larger nerve with expanded axons had far fewer mitochondria (Fig. 9B) . Similar nerves showed other signs of axon pathology, including disorganized axoplasm and swelling of the internal mesaxon in many axons (Fig. 9C) . When quantified from multiple electron micrographs of nerves with high axon density, we found that axon expansion was strongly associated with decreased density of mitochondria (Fig. 9D) .
Axon expansion and survival are tied to IOP
Earlier we explained that nerve size is predominantly determined by age and not IOP (Fig. 1) and that nerve expansion is associated with common measures of pathogenesis (Figs. 2 and 3) . These observations beg the question of what role IOP plays in determining axonal changes for aged animals. In our sample of older nerves (9e13 months), axon size increased significantly with IOP (r ¼ 0.72, p < 0.001), with a commensurate IOP-dependent decrease in axon density (r ¼ À0.69, p ¼ 0.002; Fig. 10A ). Even within this fixed age group, nerve size varied greatly (0.07e0.14 mm 2 ); as it increased, so did axon area (r ¼ 0.57, p ¼ 0.01, Fig. 10B ). Since nerve size for this group was not greatly influenced by IOP (see results section for Fig. 1 ), we conclude that elevations in IOP and enlargement for aged nerves independently influence axon expansion and therefore axon density. This point is reinforced further in Fig. 10B , which indicates that those nerves from eyes with IOP !21 mmHG range in size greatly (filled symbols). Thus, large, aged nerves are not necessarily the same nerves exposed in vivo to the highest IOP. Finally, we asked what factor most influences axon enlargement prior to frank loss, as documented in our micrographs (Figs. 4, 6, and 9 ) and in our comparison decreases as axon size increases (r ¼ À0.535, p ¼ 0.002). The linear regression was similar for the subset of nerves with axon density >5.0 Â 10 5 axons/mm 2 (filled symbols; p ¼ 0.32). Right: for the complete set of nerves with glial quantification, CoM increases with axon expansion (r ¼ 0.32, p ¼ 0.036). Regression line for nerves with axon area below 0.50 mm 2 is repeated from the left panel for comparison (dashed line). with axon density (Fig. 5 ). For the group of highest axon density nerves (top 20%, as in Fig. 5 ), mean axon area was strongly predicted by nerve size (Fig. 10C ; r ¼ 0.58, p ¼ 0.01). For this group, IOP did not predict axon size (r ¼ 0.31, p ¼ 0.38), nor did age (r ¼ 0.10, p ¼ 0.68). This is most interesting, because for the same top density nerves, age strongly influenced nerve size (r ¼ 0.59, p ¼ 0.008) and IOP (r ¼ 0.86, p ¼ 0.001; data not shown), consistent with the overall trend in our sample (Fig. 1) .
Discussion
Intrinsic variability in optic nerve pathology is a signature feature of the DBA/2J mouse model of glaucoma Schlamp et al., 2006; Inman et al., 2006; Saleh et al., 2007; Scholz et al., 2008) . A DBA/2J nerve unaffected by disease will demonstrate a mean axon packing density of 5.0e6.0 Â 10 5 axons/mm 2 (Inman et al., 2006) . When multiplied by the cross-sectional nerve area delineated within the layers of pia and dura mater, this leads to an estimated total number of axons of 50,000e60,000, comparable to that in C57/B6 nerve (Williams et al., 1996; Scholz et al., 2008) . Nerves with the worst pathology often demonstrate a packing density less than about 100,000 axons/mm 2 (Scholz et al., 2008) . Here, nerves with pathology so severe that identification of intact myelin sheaths was too ambiguous to quantify were excluded, since we are interested in early changes associated with progression.
Based on this restricted sample, we found that with age, the cross-sectional area of the myelinated segment of the DBA/2J optic nerve tends to increase (Fig. 1) . Nerve size ranges from about 0.06 mm 2 at 2 months of age to as high as 0.16 mm 2 at 10e12 months. Since IOP increased with age in our sample as expected, nerve size also tended to increase with IOP, but not significantly (Fig. 1D) . A previous study using a smaller sample of nerves hinted at a modest difference in nerve size between ages that was not systematic, though the range was highly variable (0.07e0.11 mm 2 , p ¼ 0.08; Inman et al., 2006) . We now interpret this variability as indicative of the age-dependent increase in size. Expansion of the nerve generally was associated with increased pathology, including diminished axon packing density and increased incidence of degenerating profiles (Figs. 2 and 3) . Glial coverage of the nerve, indicative of gliosis, also tended to increase, though variability was high (Fig. 3D) . A similar result can be gleaned from Scholz et al. (2008) , in which an 11 month DBA/2J nerve with severe axonal pathology was roughly 25% larger than a 10 month nerve with none (their Fig. 4) .
We also found that the mean cross-sectional area of surviving axons increased as the nerve expanded ( Fig. 3C ). Perhaps our most important and novel result is that many nerves retained their high axon packing density (>5.0 Â 10 5 axons/mm 2 ) even as nerve area increased. For these nerves e matched for high axon density e axon size also increased. This correlation was highly significant for nerves with the top 20% of axon densities (Fig. 10C ). We found that axon density remained relatively invariant up to a mean axon area of 0.45e0.50 mm 2 (Fig. 5 ). In this sense, modest axonal enlargement with nerve expansion presages degeneration; once this threshold is Note well-ordered packing of neurofilaments and microtubules in axoplasm and multiple mitochondria (m). Mean axon area is small (0.31 mm 2 ). B. A 9 month nerve also has high axon density (6.0 Â 10 5 axons/mm 2 ) but increased mean axon area (0.40 mm 2 ) and nerve size (0.091 mm 2 ). Micrograph shows fewer mitochondria. C. A larger 9 month nerve (0.10 mm 2 ) with high axon density (5.6 Â 10 5 axons/mm 2 ) has disordered axoplasm, few discernible mitochondria, and distended mesaxon compartments in several axons (arrowheads). Mean axon area is 0.40 mm 2 . D. In a sample of high-density nerves (5.2e6.2 Â 10 5 axons/mm 2 ), mitochondrial density decreases as mean axon area increases (r ¼ À0.831, p ¼ 0.003). Scale ¼ 0.5 mm.
reached, axon density decreases rapidly with increasing mean axon size up to an average size of 0.7e0.8 mm 2 (Fig. 5 ). The axon expansion noted here is gradual, which leads us to believe that the mechanism of expansion differs from the relatively quick axonal swelling and distension observed after trauma (Povlishock and Becker, 1985) . Even so, expanded axons showed signs of early axonopathy. These features included disorganized and expanded axoplasm, poorly articulated microtubules and neurofilaments, deformation of the mesaxon and axolemma, and increased accumulation of hyperphosphorylated neurofilaments (Figs. 4, 6 and 9) . The latter is indicative of challenged axonal transport (Goldstein et al., 1987; Shea and Chan, 2008) , which is one of the earliest pathogenic events in DBA/2J glaucoma (Crish et al., 2010; Calkins, 2012) . Thus, axon expansion and diminished anterograde transport probably go hand-in-hand with accumulation of phosphorylated neurofilaments and disordered axoplasm (Jakobs et al., 2005; Howell et al., 2007b; Soto et al., 2008) .
Hypertrophy of glial processes in the optic nerve, especially of astrocyte processes, is a prominent characteristic of substantial axon loss in glaucoma (Hernandez, 2000) , including the DBA/2J mouse (Jakobs et al., 2005; Bosco et al., 2008) . Importantly, our results demonstrate that as axons expand early prior to frank loss, the ramification of astrocyte processes in the inter-axonal space actually diminishes (Figs. 4 and 6) . This finding is consistent with two studies, both involving acute elevations in IOP. In the first, short-term elevations in IOP (7 days) in a rat model reduced GFAP label in the optic nerve head concurrent with axonal enlargement and increased levels of phosphorylated neurofilaments; significant axon loss occurred later (Johnson et al., 2000) . In another acute model, an early phase of reactive astrocyte gliosis involves retraction of processes from the center of the nerve prior to re-extension (Sun et al., 2013) . In the DBA/2J, we found that with early axon expansion, the center of mass for glial ramification changed from an even distribution across the nerve to one skewed towards the edge of nerve ( Figs. 7 and 8) . As axons continued to expand beyond the threshold for overt loss, the center of mass returned to an even distribution (Fig. 8, right panel) . This result stands in contrast to those from another inducible model in which astrocyte processes in the optic nerve head actually appear to detach from the edge of the nerve (Dai et al., 2012) .
Some features of the early pathogenesis we describe can be gleaned as well from other optic nerve injury or disease models. RGC axonal diameter increases in a mouse model of Batten disease concordant with loss of axon density and an overall loss of uniformity and integrity (Sappington et al., 2003) . Additionally, hints of swelling mesaxons, poor articulation of microtubules and neurofilaments within the axoplasm, and astrocyte remodeling are evident in a rat model of chronic secondary degeneration after partial optic nerve transection (Payne et al., 2012) . Nerves vulnerable to secondary degeneration also demonstrate increased markers of oxidative stress and upregulated levels of myelin basic protein throughout the partially transected nerve (Fitzgerald et al., 2010) . Thus, our findings may be relevant to the degeneration of retinal ganglion cell axons more generally. Fig. 10 . IOP is linked to axon expansion and survival for aged nerves. A. For a sample of aged (9e13 month) nerves, mean axon area expands with increasing IOP (r ¼ 0.72, p < 0.001). Axon density (right panel) accordingly diminishes (r ¼ À0.69, p ¼ 0.002). B. For the same set of aged nerves, axon size also increases with nerve expansion (r ¼ 0.57, p ¼ 0.01). Nerves from eyes with IOP !21 mmHG are indicated (filled circles). Nerve with largest axons (*) has been excluded from regression line. C. For the group of nerves with the highest axon densities (top 20%; 5.6e6.2 Â 10 5 axons/mm 2 ), mean axon area increases with nerve expansion (r ¼ 0.58, p ¼ 0.01).
What might be the significance of astrocyte retraction with early axon and nerve expansion? We found that nerves with axon expansion prior to frank loss demonstrated diminished numbers of mitochondria per unit area of tissue with increasing axon size ( Fig. 9 ). One estimate suggests that astrocytes normally account for more than 70% of the mitochondria in the optic nerve (Perge et al., 2009) . Thus, reduced ramification in the extra-axonal space could induce a local depletion of available energy for axons already challenged by glaucomatous stressors. This is consistent with our earlier work in the DBA/2J showing an age-and IOP-related decrease in optic nerve ATP (Baltan et al., 2010) . Ganglion cell axons are generally small compared to other white matter tracts (Perge et al., 2009) , and there are numerous features that render them energy-demanding (Calkins, 2012) . Diminished bioenergetic resources could be a primary inducer of progression in glaucoma (Li et al., 2015) . Our data certainly support this hypothesis, as does new evidence for reduced oxidative capacity for mitochondria in DBA/2J optic nerve axons (Coughlin et al., 2015) .
A previous study proposed that mechanisms of degeneration in glaucoma differ between the center of the nerve, based on vascular insufficiency, and the edge, where IOP may have the most robust compressive effect (Quigley et al., 1980) . While we do not address the spatial specificity of disease-relevant stressors in our study, our data do hint at two independent mechanisms of early progression. Our data show that both IOP and nerve expansion are associated with axon enlargement independently (Fig. 10) , though age is the predominant determinant of both (Fig. 1) . However, for nerves in our sample with the highest axon densities, ironically only nerve size itself and not age or IOP was a strong predictor of axon size (Fig. 10C) , as was astrocyte center of mass (Fig. 8) . Thus, prior to loss of axons, the retreat of astrocyte processes from the nerve center and nerve expansion both predict very well axon enlargement (Fig. 8, left panel; Fig. 10C ). The question becomes which change occurs first e axon expansion, nerve enlargement, or astrocyte remodeling? For the highest density nerves, astrocyte center of mass tends to decrease with increasing nerve size, though this was not significant (r ¼ À0.48; p ¼ 0.08, data not shown), and was not predicted by age (r ¼ 0.14, p ¼ 0.61). In this case, we are left with a model in which age-related nerve expansion drives critical interactions between axons and astrocyte processes that ultimately undermine axon survival.
